Literature DB >> 17179034

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

Victor J Dzau1, Elliott M Antman, Henry R Black, David L Hayes, JoAnn E Manson, Jorge Plutzky, Jeffrey J Popma, William Stevenson.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17179034     DOI: 10.1161/CIRCULATIONAHA.106.655688

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  95 in total

Review 1.  Age-related cardiovascular disease and the beneficial effects of calorie restriction.

Authors:  Miranda M Y Sung; Jason R B Dyck
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Stopping the cardiovascular disease continuum: Focus on prevention.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2010-03-26

Review 3.  Vasculopathy of Aging and the Revised Cardiovascular Continuum.

Authors:  Su-A Kim; Jeong Bae Park; Michael F O'Rourke
Journal:  Pulse (Basel)       Date:  2015-08-20

4.  Can we learn more about the etiology of cardiovascular disease?

Authors:  Lewis H Kuller
Journal:  Eur J Epidemiol       Date:  2007-02-28       Impact factor: 8.082

5.  The Italian MacNew heart disease health-related quality of life questionnaire: a validation study.

Authors:  Francesco Fattirolli; Niccolò Marchionni; Stefan Höfer; Pantaleo Giannuzzi; Elisabetta Angelino; Paolo Fioretti; Daniela Miani; Neil Oldridge
Journal:  Intern Emerg Med       Date:  2015-02-10       Impact factor: 3.397

6.  Supramaximal dose of candesartan in proteinuric renal disease.

Authors:  Ellen Burgess; Norman Muirhead; Paul Rene de Cotret; Anthony Chiu; Vincent Pichette; Sheldon Tobe
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

7.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

8.  Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.

Authors:  Dao-Fu Dai; Tony Chen; Hazel Szeto; Madeline Nieves-Cintrón; Vassily Kutyavin; Luis F Santana; Peter S Rabinovitch
Journal:  J Am Coll Cardiol       Date:  2011-05-27       Impact factor: 24.094

Review 9.  Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.

Authors:  John W Wright; Shigehiko Mizutani; Joseph W Harding
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

10.  Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men.

Authors:  B M Hoffman; A Sherwood; P J Smith; M A Babyak; P M Doraiswamy; A Hinderliter; J A Blumenthal
Journal:  Int J Impot Res       Date:  2009-09-24       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.